Jena, Germany

Herman Berg

This inventor holds 1 USPTO granted patent. Top assignee: Genetronics, Inc.. Active years: 2007.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Herman Berg - Innovator in Photodynamic Therapy

Introduction

Herman Berg is a notable inventor based in Jena, Germany. He has made significant contributions to the field of photodynamic therapy, particularly in enhancing the effectiveness of cytotoxic agents. His innovative approach combines electroporation with photosensitive agents to improve cell death in targeted therapies.

Latest Patents

Herman Berg holds a patent titled "Synergism of photodynamic and electropermeation effect on cell vitality as a novel cytotoxic agent." This invention is based on the discovery that electroporation of a photosensitive agent in a cell, followed by activation of the agent, results in more effective killing of the electroporated cell compared to cells exposed to the agent alone. The method involves providing a photosensitive agent to a cell, applying an electric pulse to electroporate the cell, and then applying light of an activatable wavelength to activate the agent, thereby inhibiting cell growth or enhancing cell death. He has 1 patent to his name.

Career Highlights

Herman Berg is associated with Genetronics, Inc., where he continues to develop innovative solutions in the field of medical technology. His work focuses on improving therapeutic techniques that can lead to better patient outcomes.

Collaborations

Herman collaborates with Maya Lambreya, contributing to advancements in their shared field of research. Their partnership aims to explore new methodologies and applications in photodynamic therapy.

Conclusion

Herman Berg's contributions to the field of photodynamic therapy exemplify the impact of innovative thinking in medical science. His patent reflects a significant advancement in enhancing the efficacy of cytotoxic agents, paving the way for improved treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…